UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2019
OR
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO |
Commission File Number 001-38945
VERICITY, INC.
(Exact name of Registrant as specified in its Charter)
Delaware |
|
46-2348863 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
8700 W. Bryn Mawr Avenue, Suite 900S, Chicago Illinois |
|
60631 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (312) 288-0073
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol |
|
Name on each exchange on which registered |
Common Stock, Par Value $0.001 per share |
|
VERY |
|
NASDAQ Capital Market |
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☒ NO ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). YES ☒ NO ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☐ |
Non-accelerated filer |
|
☒ |
|
Smaller reporting company |
|
☒ |
Emerging growth company |
|
☒ |
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO ☒
The number of shares of Registrant’s Common Stock outstanding as of November 14, 2019 was 14,875,000.
|
|
|
|
Page |
|
|
|
|
|
|
|
PART I – |
|
|
1 |
||
Item 1. |
|
|
|
|
|
|
|
|
1 |
||
|
|
|
2 |
||
|
|
Interim Condensed Consolidated Statements of Comprehensive Income (Loss) |
|
3 |
|
|
|
Interim Condensed Consolidated Statements of Changes in Equity |
|
4 |
|
|
|
|
5 |
||
|
|
Notes the Interim Condensed Consolidated Financial Statements |
|
6 |
|
|
|
|
|
6 |
|
|
|
|
|
10 |
|
|
|
|
|
15 |
|
|
|
|
|
15 |
|
|
|
|
|
15 |
|
|
|
|
|
16 |
|
|
|
|
|
18 |
|
|
|
|
|
19 |
|
|
|
|
|
23 |
|
|
|
|
|
23 |
|
|
|
|
|
23 |
|
|
|
|
|
25 |
|
|
|
|
|
|
|
Item 2. |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|
26 |
|
Item 4. |
|
|
39 |
||
|
|
|
|
|
|
PART II – |
|
|
40 |
||
Item 1. |
|
|
40 |
||
Item 1A. |
|
|
40 |
||
Item 2. |
|
|
40 |
||
Item 3. |
|
|
40 |
||
Item 4. |
|
|
40 |
||
Item 5. |
|
|
40 |
||
Item 6. |
|
|
41 |
||
|
|
|
42 |
Item I. Financial Statements
Vericity, Inc.
Interim Condensed Consolidated Balance Sheets
(dollars in thousands)
|
|
September 30, |
|
|
December 31, |
|
||
|
|
2019 |
|
|
2018 |
|
||
|
|
(Unaudited) |
|
|
(Audited) |
|
||
ASSETS: |
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
Fixed maturities – available-for-sale – at fair value (amortized cost; $301,130 and $304,303) |
|
$ |
323,727 |
|
|
$ |
306,586 |
|
Equity securities – available-for-sale – at fair value (cost; $104 and $99) |
|
|
104 |
|
|
|
99 |
|
Equity securities – trading – at fair value (cost; $6,223 and $6,328) |
|
|
5,298 |
|
|
|
4,823 |
|
Short-term investments - at fair value (amortized cost; $71,190 and $0) |
|
|
71,204 |
|
|
|
— |
|
Mortgage loans (net of valuation allowances of $53 and $236) |
|
|
53,112 |
|
|
|
50,830 |
|
Limited partnership interests |
|
|
— |
|
|
|
118 |
|
Policyholder loans |
|
|
5,874 |
|
|
|
5,623 |
|
Total investments |
|
|
459,319 |
|
|
|
368,079 |
|
Cash and cash equivalents |
|
|
79,589 |
|
|
|
20,984 |
|
Accrued investment income |
|
|
2,592 |
|
|
|
2,985 |
|
Reinsurance recoverable |
|
|
134,073 |
|
|
|
136,601 |
|
Deferred policy acquisition costs |
|
|
85,681 |
|
|
|
84,567 |
|
Commissions and agent balances (net of allowances of $567 and $562) |
|
|
10,697 |
|
|
|
1,864 |
|
Intangible assets |
|
|
1,655 |
|
|
|
1,716 |
|
Deferred income tax assets, net |
|
|
7,584 |
|
|
|
10,663 |
|
Other assets |
|
|
25,507 |
|
|
|
27,511 |
|
Total assets |
|
|
806,697 |
|
|
|
654,970 |
|
LIABILITIES AND EQUITY: |
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
Future policy benefits and claims |
|
|
334,558 |
|
|
|
320,397 |
|
Policyholder account balances |
|
|
88,947 |
|
|
|
93,051 |
|
Other policyholder liabilities |
|
|
22,363 |
|
|
|
25,738 |
|
Policy dividend obligations |
|
|
11,656 |
|
|
|
9,383 |
|
Reinsurance liabilities and payables |
|
|
6,297 |
|
|
|
6,167 |
|
Long-term debt |
|
|
15,037 |
|
|
|
10,294 |
|
Short-term debt |
|
|
3,840 |
|
|
|
3,072 |
|
Other liabilities |
|
|
15,318 |
|
|
|
14,678 |
|
Total liabilities |
|
|
498,016 |
|
|
|
482,780 |
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
Equity: |
|
|
|
|
|
|
|
|
Common stock, $.001 par value, 30,000,000 shares authorized, 14,875,000 shares, issued and outstanding |
|
|
15 |
|
|
|
— |
|
Additional paid-in capital |
|
|
132,818 |
|
|
|
— |
|
Retained earnings |
|
|
165,757 |
|
|
|
174,558 |
|
Accumulated other comprehensive income (loss) |
|
|
10,091 |
|
|
|
(2,368 |
) |
Total equity |
|
|
308,681 |
|
|
|
172,190 |
|
Total liabilities and equity |
|
$ |
806,697 |
|
|
$ |
654,970 |
|
See notes to interim condensed consolidated financial statements
1
Interim Condensed Consolidated Statements of Operations
(dollars in thousands, except earnings per share)
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
||||||||||
|
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
||||
|
|
(Unaudited) |
|
|
(Unaudited) |
|
||||||||||
REVENUES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net insurance premiums |
|
$ |
24,424 |
|
|
$ |
22,360 |
|
|
$ |
73,304 |
|
|
$ |
65,462 |
|
Net investment income |
|
|
4,177 |
|
|
|
3,817 |
|
|
|
11,678 |
|
|
|
11,281 |
|
Net realized investment (losses) gains |
|
|
(213 |
) |
|
|
12 |
|
|
|
736 |
|
|
|
133 |
|
Earned commissions |
|
|
4,540 |
|
|
|
3,420 |
|
|
|
13,435 |
|
|
|
10,115 |
|
Insurance lead sales |
|
|
1,650 |
|
|
|
1,838 |
|
|
|
4,529 |
|
|
|
6,143 |
|
Other income |
|
|
39 |
|
|
|
36 |
|
|
|
180 |
|
|
|
193 |
|
Total revenue |
|
|
34,617 |
|
|
|
31,483 |
|
|
|
103,862 |
|
|
|
93,327 |
|
BENEFITS AND EXPENSES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Life, annuity, and health claim benefits |
|
|
16,243 |
|
|
|
13,484 |
|
|
|
48,573 |
|
|
|
40,075 |
|
Interest credited to policyholder account balances |
|
|
900 |
|
|
|
929 |
|
|
|
2,538 |
|
|
|
2,718 |
|
Operating costs and expenses |
|
|
23,554 |
|
|
|
18,232 |
|
|
|
60,817 |
|
|
|
53,260 |
|
Amortization of deferred policy acquisition costs |
|
|
3,029 |
|
|
|
2,714 |
|
|
|
9,551 |
|
|
|
8,330 |
|
Other expenses |
|
|
20 |
|
|
|
40 |
|
|
|
62 |
|
|
|
123 |
|
Total benefits and expenses |
|
|
43,746 |
|
|
|
35,399 |
|
|
|
121,541 |
|
|
|
104,506 |
|
(Loss) income from operations before income tax |
|
|
(9,129 |
) |
|
|
(3,916 |
) |
|
|
(17,679 |
) |
|
|
(11,179 |
) |
Income tax (benefit) expense |
|
|
(591 |
) |
|
|
(1,051 |
) |
|
|
(307 |
) |
|
|
(1,915 |
) |
Net (loss) income |
|
$ |
(8,538 |
) |
|
$ |
(2,865 |
) |
|
$ |
(17,372 |
) |
|
$ |
(9,264 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro forma earnings per share for the periods |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
||||||||||
|
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
||||
|
|
(Unaudited) |
|
|
(Unaudited) |
|
||||||||||
Weighted average shares outstanding |
|
|
14,875,000 |
|
|
|
14,875,000 |
|
|
|
14,875,000 |
|
|
|
14,875,000 |
|
Basic earnings per share |
|
$ |
(0.57 |
) |
|
$ |
(0.19 |
) |
|
$ |
(1.17 |
) |
|
$ |
(0.62 |
) |
Diluted earnings per share |
|
$ |
(0.57 |
) |
|
$ |
(0.19 |
) |
|
$ |
(1.17 |
) |
|
$ |
(0.62 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The pro forma earnings per common share—basic and diluted—presented on the above Consolidated Statements of Operations and Comprehensive Income (Loss) is intended to depict the impact of the Conversion because neither Vericity, Inc., nor the Predecessor, had, prior to the Conversion, any outstanding common shares. The above table presents the pro forma net loss and weighted average common shares outstanding used in the computation of earnings per common share and earnings per common share – assuming dilution. |
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See notes to interim condensed consolidated financial statements
2
Interim Condensed Consolidated Statements of Comprehensive Income (Loss)
(dollars in thousands)
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
||||||||||
|
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
||||
|
|
(Unaudited) |
|
|
(Unaudited) |
|
||||||||||
Net (loss) income |
|
$ |
(8,538 |
) |
|
$ |
(2,865 |
) |
|
$ |
(17,372 |
) |
|
$ |
(9,264 |
) |
Comprehensive income (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized gains (losses) on investments |
|
|
3,153 |
|
|
|
(1,156 |
) |
|
|
12,459 |
|
|
|
(8,980 |
) |
Total comprehensive income (loss) |
|
|
3,153 |
|
|
|
(1,156 |
) |
|
|
12,459 |
|
|
|
(8,980 |
) |
Total comprehensive (loss) income |
|
$ |
(5,385 |
) |
|
$ |
(4,021 |
) |
|
$ |
(4,913 |
) |
|
$ |
(18,244 |
) |
See notes to interim condensed consolidated financial statements
3
Interim Condensed Consolidated Statements of Changes in Equity
(dollars in thousands)
|
|
Nine Months Ended September 30, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
|
|
(Unaudited) |
|
|||||
COMMON STOCK |
|
|
|
|
|
|
|
|
Balance – beginning of period |
|
$ |
— |
|
|
$ |
— |
|
Common stock issued |
|
|
15 |
|
|
|
— |
|
Balance – end of period |
|
$ |
15 |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
ADDITIONAL PAID-IN CAPITAL |
|
|
|
|
|
|
|
|
Balance – beginning of period |
|
$ |
— |
|
|
$ |
— |
|
Proceeds net of offering costs |
|
|
132,818 |
|
|
|
— |
|
Balance – end of period |
|
$ |
132,818 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
RETAINED EARNINGS |
|
|
|
|
|
|
|
|
Balance – beginning of period |
|
$ |
174,558 |
|
|
$ |
188,405 |
|
Cumulative effect adjustment from changes in accounting guidance, net of tax |
|
|
8,571 |
|
|
|
— |
|
Balance after adjustments – beginning of period |
|
|
183,129 |
|
|
|
188,405 |
|
Net (loss) income |
|
|
(17,372 |
) |
|
|
(9,264 |
) |
Balance – end of period |
|
$ |
165,757 |
|
|
$ |
179,141 |
|
|
|
|
|
|
|
|
|
|
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS): |
|
|
|
|
|
|
|
|
Balance – beginning of period |
|
$ |
(2,368 |
) |
|
$ |
7,798 |
|
Other comprehensive income (loss) attributable to the Company |
|
|
12,459 |
|
|
|
(8,980 |
) |
Balance – end of period |
|
$ |
10,091 |
|
|
$ |
(1,182 |
) |
TOTAL STOCKHOLDERS' EQUITY |
|
$ |
308,681 |
|
|
$ |
177,959 |
|
See notes to interim condensed consolidated financial statements
4
Interim Condensed Consolidated Statements of Cash Flows
(dollars in thousands)
|
|
Nine Months Ended September 30, |
|
|||||
|
|
2019 |
|
|
2018 |
|
||
|
|
(Unaudited) |
|
|||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
|
|
|
|
Net (loss) income |
|
$ |
(17,372 |
) |
|
$ |
(9,264 |
) |
Adjustments to reconcile net (loss) to net cash provided (used) by operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization and other non-cash items |
|
|
1,228 |
|
|
|
1,305 |
|
Interest credited to policyholder account balances |
|
|
2,538 |
|
|
|
2,718 |
|
Deferred income tax |
|
|
(233 |
) |
|
|
(1,943 |
) |
Realized investment gains |
|
|
(736 |
) |
|
|
(133 |
) |
Interest expense |
|
|
803 |
|
|
|
316 |
|
Change in: |
|
|
|
|
|
|
|
|
Trading securities |
|
|
(268 |
) |
|
|
(288 |
) |
Accrued investment income |
|
|
393 |
|
|
|
508 |
|
Reinsurance recoverable |
|
|
2,528 |
|
|
|
3,851 |
|
Deferred policy acquisition costs |
|
|
(1,114 |
) |
|
|
(2,309 |
) |
Commissions and agent balances |
|
|
(263 |
) |
|
|
211 |
|
Other assets |
|
|
(3,447 |
) |
|
|
(1,139 |
) |
Insurance liabilities |
|
|
8,499 |
|
|
|
2,924 |
|
Other liabilities |
|
|
707 |
|
|
|
(1,282 |
) |
Net cash (used) provided by operating activities |
|
|
(6,737 |
) |
|
|
(4,525 |
) |
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
|
Sales, maturities and repayments of: |
|
|
|
|
|
|
|
|
Fixed maturity securities |
|
|
74,202 |
|
|
|
53,097 |
|
Equity securities |
|
|
— |
|
|
|
10 |
|
Mortgage loans |
|
|
2,439 |
|
|
|
785 |
|
Limited partnerships |
|
|
152 |
|
|
|
3,323 |
|
Purchases of: |
|
|
|
|
|
|
|
|
Fixed maturity securities |
|
|
(71,012 |
) |
|
|
(46,969 |
) |
Short-term investments |
|
|
(71,001 |
) |
|
|
— |
|
Mortgage loans |
|
|
(4,508 |
) |
|
|
(8,423 |
) |
Limited partnerships |
|
|
(38 |
) |
|
|
— |
|
Change in policyholder loans, net |
|
|
(251 |
) |
|
|
321 |
|
Other investments, net |
|
|
(3,406 |
) |
|
|
(3,599 |
) |
Net cash (used) provided by investing activities |
|
|
(73,423 |
) |
|
|
(1,455 |
) |
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock in initial public offering, net of underwriting commission and offering costs |
|
|
140,572 |
|
|
|
— |
|
Debt issued |
|
|
9,934 |
|
|
|
13,371 |
|
Debt repaid |
|
|
(5,226 |
) |
|
|
(3,584 |
) |
Deposits to policyholder account balances |
|
|
346 |
|
|
|
498 |
|
Withdrawals from policyholder account balances |
|
|
(6,861 |
) |
|
|
(6,222 |
) |
Net cash provided (used) by financing activities |
|
|
138,765 |
|
|
|
4,063 |
|
Net increase (decrease) in cash and cash equivalents |
|
|
58,605 |
|
|
|
(1,917 |
) |
Cash and cash equivalents – beginning of period |
|
|
20,984 |
|
|
|
11,766 |
|
Cash and cash equivalents – end of period |
|
$ |
79,589 |
|
|
$ |
9,849 |
|
Supplemental cash flow information |
|
|
|
|
|
|
|
|
Non-cash transactions |
|
|
|
|
|
|
|
|
Cumulative effect adjustment from changes in accounting guidance, net of tax |
|
$ |
8,571 |
|
|
|
— |
|
Registration costs included in other assets at December 31, 2018 |
|
|
7,739 |
|
|
|
— |
|
See notes to interim condensed consolidated financial statements
5
Notes to Interim Condensed Consolidated Financial Statements
(dollars in thousands)
Note 1 – Summary of Significant Accounting Policies
Description of Business
Vericity, Inc. (the Company) is a Delaware corporation organized to be the stock holding company for Members Mutual Holding Company (Members Mutual) and its subsidiaries. On August 7, 2019, Vericity, Inc. completed the initial public offering of 14,875,000 shares of its common stock at a price of $10.00 per share (the IPO). The IPO was conducted in connection with the conversion of Members Mutual from mutual to stock form and the acquisition by Vericity, Inc. of all of the capital stock of Members Mutual following its conversion to stock form after its plan of conversion and amended and restated articles of incorporation were approved at a special meeting of eligible members on August 6, 2019 (the Conversion). As a result of the Conversion, Vericity, Inc. became the holding company for converted Members Mutual and its indirect subsidiaries, including Fidelity Life Association (Fidelity Life) and Efinancial, LLC.
Vericity, Inc. operates as a holding company and currently has no other business operations. Fidelity Life is an Illinois‑domiciled life insurance company that was founded in 1896. Fidelity Life markets life insurance products through independent and affiliated distributors and is licensed in the District of Columbia and all states, except New York and Wyoming. Efinancial, LLC (Efinancial) markets life and other products for non‑affiliated insurance companies and sells life products for Fidelity Life.
The accompanying interim condensed consolidated financial statements present the accounts of Vericity, Inc. and subsidiaries for the three and nine months ended September 30, 2019 and September 30, 2018 and at September 30, 2019 and December 31, 2018. These interim condensed consolidated financial statements and notes should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report for the year ended December 31, 2018. The results of operations for the interim periods should not be considered indicative of results to be expected for the full year.
6
These interim condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). The unaudited interim condensed consolidated financial information furnished herein reflects all adjustments which are, in the opinion of management, necessary to fairly state the results for the interim periods presented. All such adjustments are of a normal recurring nature. All intercompany accounts and transactions have been eliminated in consolidation. The consolidated results of operations for the interim periods presented are not necessarily indicative of results for the full year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted from this report, as is permitted by such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the financial statements as of and for the year ended December 31, 2018, and notes thereto, included in the Form S-1.
Use of Estimates
The preparation of interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The more significant estimates employed in the preparation of the interim condensed consolidated financial statements include the determination of the valuation of investments in fixed maturities and equity securities, investment impairments, the valuation of deferred tax assets, future policy benefits and other policyholder liabilities.
Short-Term Investments
Short-term investments are classified as available-for-sale and are reported at fair value. Changes in fair value are reported as unrealized gains or losses and are a component of accumulated other comprehensive income (AOCI), net of applicable deferred income taxes. Fair value is based on quoted market prices, when available. When quoted market prices are not available, fair value is estimated by discounting fixed maturity securities cash flows to reflect interest rates currently being offered on similar terms to borrowers of similar credit quality, by quoted market prices of comparable instruments, and by independent pricing sources. See Note 7 for further discussion on inputs and assumptions used to estimate fair value.
Revenue Recognition
We adopted Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 606”) on January 1, 2019. The majority of our revenue-generating arrangements are premiums received from insurance contracts and therefore are excluded from the scope of ASU 606. Life and health insurance contract premiums are recognized as income when due from policyholders. Deposits on deposit-type contracts are entered directly as a liability when cash is received.
Commission revenue from the sale of insurance products by Efinancial is recognized once the insurance policy is issued by the insurance company and accepted by the customer (policy placement) and recorded as commission receivable, net of any advances received. Provision is made for commission revenue that, based on experience, will ultimately not be earned due to the customer discontinuing the underlying insurance policy. Commission revenue that Efinancial earns from the sale of insurance products where Efinancial acts as the general agent (wholesale distribution) is recorded net of related commission expense paid to the writing agency.
Our primary revenue-generating arrangements that are within the scope of ASU 606 are our brokerage arrangements with third-parties. In these arrangements, our customer is the insurance carrier and we have a single performance obligation to place a policy for the insurance carrier. Our performance obligation is satisfied at the point in time when the policy is placed, which is the point in time when the customer obtains control over the policy and has the right to use and obtain the benefits from the policy. In these arrangements, depending on the number of years the policy is in force, a significant majority of our consideration is received in the first year. In addition to the first-year consideration, depending on the specific carrier and product involved, we may also be entitled to renewal commissions over the period of time the policy remains in force. Our consideration is variable based on the amount of time we estimate a policy will remain in force. We estimate the amount of variable consideration that we expect to receive based on our historical experience or carrier experience to the extent available, industry data and our expectations as to future persistency rates. Additionally, we consider application of the constraint and only recognize the amount of variable consideration that we believe is probable to be received and will not be subject to a significant revenue reversal. We monitor and update this estimate at each reporting date.
Because we recognize revenue prior to being entitled to the payment for these renewal commissions, we recognize a contract asset; however, we have determined that the amount of our contract asset is immaterial. Additionally, because our brokerage arrangements consist of a single performance obligation that is satisfied at the point in time that policies are placed, we do not have
7
any remaining performance obligations in our contracts with customers. We have evaluated our arrangements and concluded that none of our brokerage arrangements include a significant financing component, and therefore do not adjust revenue for the time value of money. We have determined that any contract costs (e.g., costs to obtain or costs to fulfill) related to our brokerage arrangements are immaterial.
Our Chief Operating Decision Maker makes decisions by analyzing our segment information, which is included in Note 10. For internal decision-making purposes and external reporting purposes, we do not disaggregate revenue beyond our segment information and believe that any further disaggregation is immaterial.
Insurance lead sales include the sale of potential life insurance customer leads to outside parties including agencies and unaffiliated insurers. Sales of leads are recorded at the time the lead data is transferred to the customer and recorded as a receivable, net of allowance for returns.
Accounting Standards Adopted
In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers. The guidance is effective for interim and annual periods beginning after December 15, 2017. The core principle of the updated guidance is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments, changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. The standard excludes from its scope the accounting for insurance contracts, financial instruments, and certain other agreements that are governed under other GAAP guidance. The Company adopted the new revenue guidance effective January 1, 2019 using the modified retrospective approach.
The cumulative effect changes to the Interim Condensed Consolidated Balance Sheet for the adoption of the updated guidance on January 1, 2019 were as follows:
|
|
Balance at December 31, |
|
|
Adoption Adjustment |
|
|
Balance at January 1, |
|
|||
ASSETS: |
|
2018 |
|
|
Topic 606 |
|
|
2019 |
|
|||
Commissions and agent balances |
|
$ |
1,864 |
|
|
$ |
8,571 |
|
|
$ |
10,435 |
|
Deferred income tax assets, net |
|
$ |
10,663 |
|
|
|
— |
|
|
$ |
10,663 |
|
Retained earnings |
|
$ |
174,558 |
|
|
$ |
8,571 |
|
|
$ |
183,129 |
|
8
The impact of adoption on the Interim Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2019 and Interim Condensed Consolidated Balance Sheets as of September 30, 2019 were as follows:
|
|
Three Months Ended September 30, 2019 |
|
|||||||||
REVENUES: |
|
Before Adoption Adjustment |
|
|
Adoption Adjustment Effect |
|
|
After Adoption Adjustment |
|
|||
Earned commissions |
|
$ |
4,587 |
|
|
$ |
(47 |
) |
|
$ |
4,540 |
|
Total revenue |
|
|
34,664 |
|
|
|
(47 |
) |
|
|
34,617 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from operations before income tax |
|
$ |
(9,082 |
) |
|
$ |
(47 |
) |
|
$ |
(9,129 |
) |
Income tax (benefit) expense |
|
|
(591 |
) |
|
|
— |
|
|
|
(591 |
) |
Net (loss) income |
|
$ |
(8,491 |
) |
|
$ |
(47 |
) |
|
$ |
(8,538 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2019 |
|
|||||||||
REVENUES: |
|
Before Adoption Adjustment |
|
|
Adoption Adjustment Effect |
|
|
After Adoption Adjustment |
|
|||
Earned commissions |
|
$ |
13,283 |
|
|
$ |
152 |
|
|
$ |
13,435 |
|
Total revenue |
|
|
103,710 |
|
|
|
152 |
|
|
|
103,862 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from operations before income tax |
|
$ |
(17,831 |
) |
|
$ |
152 |
|
|
$ |
(17,679 |
) |
Income tax expense (benefit) |
|
|
(307 |
) |
|
|
— |
|
|
|
(307 |
) |
Net (loss) income |
|
$ |
(17,524 |
) |
|
$ |
152 |
|
|
$ |
(17,372 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2019 |
|
|||||||||
ASSETS: |
|
Before Adoption Adjustment |
|
|
Adoption Adjustment Effect |
|
|
After Adoption Adjustment |
|
|||
Commissions and agent balances |
|
$ |
10,545 |
|
|
$ |
152 |
|
|
$ |
10,697 |
|
Deferred income tax assets, net |
|
$ |
7,584 |
|
|
$ |
— |
|
|
$ |
7,584 |
|
LIABILITIES AND EQUITY: |
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Equity |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Retained earnings |
|
$ |
165,605 |
|
|
$ |
152 |
|
|
$ |
165,757 |
|
In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments–Overall: Recognition and Measurement of Financial Assets and Financial Liabilities. The updated guidance requires changes to the current financial instruments reporting model and is effective for annual periods beginning after December 15, 2018, and interim periods within fiscal years beginning after December 15, 2019. The Company expects that the primary effects of the new guidance will be around the accounting for equity investments. All equity investments in unconsolidated entities (other than those accounted for using the equity method of accounting) will generally be measured at fair value through earnings. There will no longer be an available-for-sale classification for changes in fair value reported in other comprehensive income (loss) for equity securities with readily determinable fair values. Under the new guidance, changes in the fair value of equity securities will be reported as net realized investment gains (losses) in the Company's consolidated Statement of Operations.
9
The Company continuously monitors its investment strategies and individual holdings with consideration of current and projected market conditions, the composition of the Company’s liabilities, projected liquidity and capital investment needs, and compliance with investment policies and state regulatory guidelines.
Available‑for‑Sale Securities
The amortized cost, gross unrealized gains, gross unrealized losses, fair value, and Other Than Temporary Impairments (OTTI) loss included in AOCI of fixed maturities available-for-sale are as follows:
|
|
September 30, 2019 |
|
|||||||||||||||||
Fixed maturities, available-for-sale |
|
Amortized Cost |
|
|
Unrealized Gain |
|
|
Unrealized Loss |
|
|
Fair Value |
|
|
OTTI Losses |
|
|||||
U.S. government and agencies |
|
$ |
16,308 |
|
|
$ |
2,272 |
|
|
$ |
— |
|
|
$ |
18,580 |
|
|
$ |
— |
|
U.S. agency mortgage-backed |
|
|
40,295 |
|
|
|
1,136 |
|
|
|
(32 |
) |
|
|
41,399 |
|
|
|
— |
|
State and political subdivisions |
|
|
20,643 |
|
|
|
2,137 |
|
|
|
(1 |
) |
|
|
22,779 |
|
|
|
— |
|
Corporate and miscellaneous |
|
|
137,171 |
|
|
|
16,018 |
|
|
|
(707 |
) |
|
|
152,482 |
|
|
|
— |
|
Foreign government |
|
|
131 |
|
|
|
37 |
|
|
|
— |
|
|
|
168 |
|
|
|
— |
|
Residential mortgage-backed securities |
|
|
7,075 |
|
|
|
491 |
|
|
|
(13 |
) |
|
|
7,553 |
|
|
|
(277 |
) |
Commercial mortgage-backed securities |
|
|
19,724 |
|
|
|
1,077 |
|
|
|
(3 |
) |
|
|
20,798 |
|
|
|
— |
|
Asset-backed securities |
|
|
59,783 |
|
|
|
408 |
|
|
|
(223 |
) |
|
|
59,968 |
|
|
|
— |
|
Total fixed maturities, available-for-sale |
|
$ |
301,130 |
|
|
$ |
23,576 |
|
|
$ |
(979 |
) |
|
$ |
323,727 |
|
|
$ |
(277 |
) |
|
|
December 31, 2018 |
|
|||||||||||||||||
Fixed maturities, available-for-sale |
|
Amortized Cost |
|
|
Unrealized Gain |
|
|
Unrealized Loss |
|
|
Fair Value |
|
|
OTTI Losses |
|
|||||
U.S. government and agencies |
|
$ |
11,459 |
|
|
$ |
1,181 |
|
|
$ |
(129 |
) |
|
$ |
12,511 |
|
|
$ |
— |
|
U.S. agency mortgage-backed |
|
|
32,811 |
|
|
|
332 |
|
|
|
(562 |
) |
|
|
32,581 |
|
|
|
— |
|